Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines

Guardado en:

Detalles Bibliográficos
Autores principales:	Cardama, Georgina A., Comin, Maria J., Hornos, Leandro, Gonzalez, Nazareno, Defelipe, Lucas, Turjanski, Adrian G., Alonso, Daniel F., Gomez, Daniel E., Lorenzano Menna, Pablo
Formato:	article
Lenguaje:	Inglés
Publicado:	Bentham Science Publishers 2014
Materias:	Cáncer Glándulas mamarias Biología molecular Células Inhibidores Tecnología médica Lucha contra las enfermedades
Acceso en línea:	http://www-biblio.inti.gob.ar:80/gsdl/collect/inti/index/assoc/HASH0115/144c5e4b.dir/doc.pdf
Aporte de:	Repositorio Institucional del Instituto Nacional de Tecnología Industrial (INTI) de Instituto Nacional de Tecnología Industrial (INTI)

id	I60-R166-HASH0115144c5e4baa803a3e2596
record_format	dspace
spelling	I60-R166-HASH0115144c5e4baa803a3e25962021-07-14 Cardama, Georgina A. Comin, Maria J. Hornos, Leandro Gonzalez, Nazareno Defelipe, Lucas Turjanski, Adrian G. Alonso, Daniel F. Gomez, Daniel E. Lorenzano Menna, Pablo openAccess Cáncer Glándulas mamarias Biología molecular Células Inhibidores Tecnología médica Lucha contra las enfermedades Bentham Science Publishers 2014 application/pdf eng article Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines http://www-biblio.inti.gob.ar:80/gsdl/collect/inti/index/assoc/HASH0115/144c5e4b.dir/doc.pdf
institution	Instituto Nacional de Tecnología Industrial (INTI)
institution_str	I-60
repository_str	R-166
collection	Repositorio Institucional del Instituto Nacional de Tecnología Industrial (INTI)
language	Inglés
orig_language_str_mv	eng
topic	Cáncer Glándulas mamarias Biología molecular Células Inhibidores Tecnología médica Lucha contra las enfermedades
spellingShingle	Cáncer Glándulas mamarias Biología molecular Células Inhibidores Tecnología médica Lucha contra las enfermedades Cardama, Georgina A. Comin, Maria J. Hornos, Leandro Gonzalez, Nazareno Defelipe, Lucas Turjanski, Adrian G. Alonso, Daniel F. Gomez, Daniel E. Lorenzano Menna, Pablo Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
topic_facet	Cáncer Glándulas mamarias Biología molecular Células Inhibidores Tecnología médica Lucha contra las enfermedades
format	article
author	Cardama, Georgina A. Comin, Maria J. Hornos, Leandro Gonzalez, Nazareno Defelipe, Lucas Turjanski, Adrian G. Alonso, Daniel F. Gomez, Daniel E. Lorenzano Menna, Pablo
author_facet	Cardama, Georgina A. Comin, Maria J. Hornos, Leandro Gonzalez, Nazareno Defelipe, Lucas Turjanski, Adrian G. Alonso, Daniel F. Gomez, Daniel E. Lorenzano Menna, Pablo
author_sort	Cardama, Georgina A.
title	Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
title_short	Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
title_full	Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
title_fullStr	Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
title_full_unstemmed	Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
title_sort	preclinical development of novel rac1-gef signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
publisher	Bentham Science Publishers
publishDate	2014
url	http://www-biblio.inti.gob.ar:80/gsdl/collect/inti/index/assoc/HASH0115/144c5e4b.dir/doc.pdf
work_keys_str_mv	AT cardamageorginaa preclinicaldevelopmentofnovelrac1gefsignalinginhibitorsusingarationaldesignapproachinhighlyaggressivebreastcancercelllines AT cominmariaj preclinicaldevelopmentofnovelrac1gefsignalinginhibitorsusingarationaldesignapproachinhighlyaggressivebreastcancercelllines AT hornosleandro preclinicaldevelopmentofnovelrac1gefsignalinginhibitorsusingarationaldesignapproachinhighlyaggressivebreastcancercelllines AT gonzaleznazareno preclinicaldevelopmentofnovelrac1gefsignalinginhibitorsusingarationaldesignapproachinhighlyaggressivebreastcancercelllines AT defelipelucas preclinicaldevelopmentofnovelrac1gefsignalinginhibitorsusingarationaldesignapproachinhighlyaggressivebreastcancercelllines AT turjanskiadriang preclinicaldevelopmentofnovelrac1gefsignalinginhibitorsusingarationaldesignapproachinhighlyaggressivebreastcancercelllines AT alonsodanielf preclinicaldevelopmentofnovelrac1gefsignalinginhibitorsusingarationaldesignapproachinhighlyaggressivebreastcancercelllines AT gomezdaniele preclinicaldevelopmentofnovelrac1gefsignalinginhibitorsusingarationaldesignapproachinhighlyaggressivebreastcancercelllines AT lorenzanomennapablo preclinicaldevelopmentofnovelrac1gefsignalinginhibitorsusingarationaldesignapproachinhighlyaggressivebreastcancercelllines
_version_	1771257700737351680

Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines

Ejemplares similares